跳至主要内容
临床试验/NCT02944669
NCT02944669Unknown不适用

Long-Term, Prospective, Non-Interventional Study Monitoring Safety and Training in Patients With Spinal Cord Injuries and Their Trained Companions Recently Initiated With the ReWalk™ Personal Device

ReWalk Robotics, Inc.3 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
3
主要终点
Long-term safety of the ReWalk Personal Device for Subjects in institutional and non- institutional environments, as measured by 12-month incidence of all Serious Adverse Events in Subjects

研究概览

简要总结

This study seeks to further evaluate the Multi-Tiered Training Program and to further explore the overall safety profile of the ReWalk Personal Device outside of the institutional setting under conditions of routine medical practice.

详细描述

This study will monitor and further describe the long-term safety of the ReWalk Personal Device for Subjects and their Companions in institutional and non-institutional environments, such as the clinic, home, and community. The study will also evaluate the adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects, their Companions, and their Clinical Trainers, monitor and further describe all ReWalk Personal Device malfunctions and screen for potential Unexpected Adverse Events.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For use in institutional and non-institutional environments: Subjects with spinal cord injury at levels T7 to L
  • Age ≥ 18 years old;
  • Hands and shoulders can support crutches or a walker;
  • Healthy bone density;
  • Skeleton does not suffer from any fractures;
  • Able to stand using a device such as EasyStand;
  • In general good health;
  • Height is between 160 cm and 190 cm (5'3" - 6'2");
  • Weight does not exceed 100 kg (220 lbs);
  • Proficiency in spoken and written English language.

排除标准

  • History of severe neurological injuries or disease other than SCI (MS, CP, ALS, TBI, etc.);
  • Severe concurrent medical disease, including infections, circulatory, heart or lung, pressure sores;
  • Severe spasticity (Ashworth 4)
  • Uncontrolled clonus;
  • Unstable spine or unhealed limbs or pelvic fractures;
  • Heterotopic ossification;
  • Significant contractures;
  • Psychiatric or cognitive situations that may interfere with proper operation of the device or participation in this study;
  • Pregnancy

结局指标

主要结局

Long-term safety of the ReWalk Personal Device for Subjects in institutional and non- institutional environments, as measured by 12-month incidence of all Serious Adverse Events in Subjects

时间窗: 12 Months

Long-term safety of the ReWalk Personal Device for Companions in institutional and non-institutional environments, as measured by 12-month incidence of all Serious Adverse Events in Companions

时间窗: 12 Months

Long-term safety of the ReWalk Personal Device for Subjects in institutional and non- institutional environments, as measured by 12-month incidence of falls and fall- associated injuries

时间窗: 12 Months

Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects, as measured by the proportion of Subjects enrolled in training who successfully complete the intended training

时间窗: 12 Months

Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects, as measured by the Subjects' abilities to navigate surfaces and environments outside of the institutional environment in accordance with their training

时间窗: 12 Months

Adequacy of the ReWalk Training Program for Subjects, measured by the proportion of Subjects who successfully completed the intended training who are able to demonstrate proficiencies at 12 months after completion of the intended training

时间窗: 12 Months

Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Companions, as measured by the proportion of Companions enrolled in training who successfully complete the intended training

时间窗: 12 Months

次要结局

  • Reliability of the ReWalk Personal Device, as measured by the rates of all device malfunctions(12 Months)
  • Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Companions, as measured by the qualitative Prescribing Physician, Clinical Trainer, Companion, and Subject responses to directed and open-ended questioning(12 Months)
  • Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Clinical Trainers, as measured by the qualitative Clinical Trainer responses to directed and open-ended questioning(12 Months)
  • Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects, as measured by the qualitative Prescribing Physician, Clinical Trainer, Companion, and Subject responses to directed and open-ended questioning(12 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验